Coming out of our research and development processing runs, we’re pleased to announce the filing of our core processing patent.
Innovation in neonatal nutrition has stalled, leaving almost all premature infants in hospital NICUs without the lifesaving benefits of an exclusive human milk diet.
“This critical step in changing the future of human milk nutrition,” shared Glenn Snow, CEO and Co-Founder of LactaLogics. “Being able to offer superior retention of proteins, immune factors, and HMOs will change the future of human milk.”
More details will be released as they come available.
